BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16886189)

  • 1. Enhancement of transdermal testosterone delivery by supersaturation.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Pharm Sci; 2006 Nov; 95(11):2373-9. PubMed ID: 16886189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of a testosterone transdermal spray.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Pharm Sci; 2006 Aug; 95(8):1693-702. PubMed ID: 16795012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antinucleants on transdermal delivery of testosterone from a spray.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Pharm Sci; 2007 Jan; 96(1):84-92. PubMed ID: 16998787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vehicle effects on the in vitro penetration of testosterone through equine skin.
    Mills PC
    Vet Res Commun; 2007 Feb; 31(2):227-33. PubMed ID: 17191091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin.
    Mills PC; Magnusson BM; Cross SE
    Vet J; 2006 Mar; 171(2):276-80. PubMed ID: 16490709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of testosterone transdermal delivery.
    Nicolazzo JA; Morgan TM; Reed BL; Finnin BC
    J Control Release; 2005 Apr; 103(3):577-85. PubMed ID: 15820405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced permeation of fentanyl from supersaturated solutions in a model membrane.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Apr; 407(1-2):72-7. PubMed ID: 21256946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation issues associated with transdermal fentanyl delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
    Choi A; Gang H; Chun I; Gwak H
    Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action.
    Thomas NS; Panchagnula R
    Eur J Pharm Sci; 2003 Jan; 18(1):71-9. PubMed ID: 12554075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK; Arora V; Iversen PL; Brand RM
    Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization.
    El-Kamel AH; Al-Fagih IM; Alsarra IA
    J Microencapsul; 2007 Aug; 24(5):457-75. PubMed ID: 17578735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of clotrimazole transdermal spray.
    Paradkar M; Thakkar V; Soni T; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2015; 41(10):1718-25. PubMed ID: 25579237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
    Watkinson RM; Guy RH; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microemulsion formulations for the transdermal delivery of testosterone.
    Hathout RM; Woodman TJ; Mansour S; Mortada ND; Geneidi AS; Guy RH
    Eur J Pharm Sci; 2010 Jun; 40(3):188-96. PubMed ID: 20304048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil.
    Al-Saidan SM; Krishnaiah YS; Chandrasekhar DV; Lalla JK; Rama B; Jayaram B; Bhaskar P
    Skin Pharmacol Physiol; 2004; 17(6):310-20. PubMed ID: 15528962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.